Kirjojen hintavertailu – 12 903 725 kirjaa ja 27 kauppaa

Kirjailija

Kirstin a. Counts

Kirjat ja teokset yhdessä paikassa: 2 kirjaa, julkaisuja vuodelta 2018, suosituimpiin kuuluu Dietary Supplements Manufacturing and Distribution: Current Good Manufacturing Practice, Labeling, and Premarket Notification, Concise Reference, Seco. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

2 kirjaa

Dietary Supplements Manufacturing and Distribution: Current Good Manufacturing Practice, Labeling, and Premarket Notification, Concise Reference, Seco
Dietary Supplements Manufacturing and Distribution is a unified reference source for the U. S. Food and Drug Administration's regulations, guidance, and associated documents pertaining to the manufacture and distribution of dietary supplements. The dietary supplement industry includes a vast array of ingredients, product forms, suppliers, manufacturers, and distributors. With such diversity in the marketplace it is important to fully understand the rules governing the industry. It is the responsibility of the participants in all stages of the manufacturing and distribution process to protect dietary supplement consumers and to provide safe and consistent products. This reference book is a compilation of 21CFR (Code of Federal Regulations, Title 21) as it applies to dietary supplements, DSHEA (Dietary Supplements Health and Education Act of 1994), DSNDCPA (Dietary Supplement and Nonprescription Drug Consumer Protection Act), and related guidance documents. Also included are selected warning letters demonstrating communications from the FDA, a combined glossary of the legally defined terms, and a detailed index. Included Documents and Features: - FDA Overview and Orientation - Introduction to Dietary Supplements - Part 1: General Enforcement Regulations - Part 101: Food Labeling - Part 111: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements - Part 119: Dietary Supplements that Present a Significant or Unreasonable Risk - Part 190: Dietary Supplements - Dietary Supplement and Nonprescription Drug Consumer Protection Act - Dietary Supplement Health and Education Act of 1994 - Guidance Documents - Sample Warning Letters - Combined Glossary and Index
Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents, Concise Reference, Second Edit
FDA Regulations and Associated Guidance Documents: - Code of Federal Regulation Title 21 Overview - Part 11 Electronic Records; Electronic Signatures (21CFR 11) and Guidance for Industry - Part 26 Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and The European Community (21CFR 26) - Part 200 Drugs: General (21CFR 200) - Part 207 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs, and The National Drug Code (21CFR 207) - Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General (21CFR 210) - Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals (21CFR 211) - Part 600 Biological Products: General (21CFR 600) - Part 807 Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices (21CFR 807) - Part 820 Quality System Regulation (21CFR 820) - Part 11, Electronic Records; Electronic Signatures - Scope and Application - Guidance for Industry and FD A Staff: Current Good Manufacturing Practice Requirements for Combination Products - Guidance for Industry: CGMP for Phase 1 Investigational Drugs - Process Validation: General Principles and Practices - PAT - A Frame work for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance - Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations - Contract Manufacturing Arrangements for Drugs: Quality Agreements - Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP - Formal Dispute Resolution: Sponsor Appeals Above the Division Level Reference Tools: - Glossaries combined in one location - GMP Keyword Index for 21CFR211 - Combined Index for all documents